183 related articles for article (PubMed ID: 21401697)
1. Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer.
Seiler R; von Gunten M; Thalmann GN; Fleischmann A
Histopathology; 2011 Mar; 58(4):571-8. PubMed ID: 21401697
[TBL] [Abstract][Full Text] [Related]
2. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.
Fleischmann A; Thalmann GN; Markwalder R; Studer UE
J Clin Oncol; 2005 Apr; 23(10):2358-65. PubMed ID: 15800327
[TBL] [Abstract][Full Text] [Related]
3. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder.
Fleischmann A; Thalmann GN; Markwalder R; Studer UE
Am J Surg Pathol; 2005 Jan; 29(1):89-95. PubMed ID: 15613859
[TBL] [Abstract][Full Text] [Related]
5. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
6. Relevance of extracapsular extension of pelvic lymph node metastasis in patients with bladder cancer treated in the contemporary era.
Kassouf W; Leibovici D; Luongo T; Munsell MF; Vakar F; Dinney CP; Grossman HB; Kamat AM
Cancer; 2006 Oct; 107(7):1491-5. PubMed ID: 16894527
[TBL] [Abstract][Full Text] [Related]
7. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
Wright JL; Lin DW; Porter MP
Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
[TBL] [Abstract][Full Text] [Related]
8. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
[TBL] [Abstract][Full Text] [Related]
9. External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy.
Masson-Lecomte A; Vordos D; Hoznek A; Yiou R; Allory Y; Abbou CC; de la Taille A; Salomon L
Ann Surg Oncol; 2013 Apr; 20(4):1389-94. PubMed ID: 23208127
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
Stein JP; Cai J; Groshen S; Skinner DG
J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
[TBL] [Abstract][Full Text] [Related]
12. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
[TBL] [Abstract][Full Text] [Related]
13. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
[TBL] [Abstract][Full Text] [Related]
14. [Significance of pelvic lymphadenectomy for the prognosis after radical cystectomy].
Leissner J; Allhoff EP; Hohenfellner R; Wolf HK
Zentralbl Chir; 2002 Apr; 127(4):315-21. PubMed ID: 12085284
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
16. High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patients.
Seiler R; von Gunten M; Thalmann GN; Fleischmann A
Hum Pathol; 2012 Feb; 43(2):269-75. PubMed ID: 21835428
[TBL] [Abstract][Full Text] [Related]
17. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.
Dorin RP; Daneshmand S; Eisenberg MS; Chandrasoma S; Cai J; Miranda G; Nichols PW; Skinner DG; Skinner EC
Eur Urol; 2011 Nov; 60(5):946-52. PubMed ID: 21802833
[TBL] [Abstract][Full Text] [Related]
18. Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy.
Bruins HM; Dorin RP; Rubino B; Miranda G; Cai J; Daneshmand S; Skinner EC
Eur Urol; 2012 Oct; 62(4):671-6. PubMed ID: 22575915
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection.
Dhar NB; Campbell SC; Zippe CD; Derweesh IH; Reuther AM; Fergany A; Klein EA
BJU Int; 2006 Dec; 98(6):1172-5. PubMed ID: 16956353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
